Apellis Pharmaceuticals Inc (APLS)
33.18
+0.04
(+0.11%)
USD |
NASDAQ |
Dec 20, 16:00
33.18
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Total Assets (Quarterly): 901.87M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen Inc | 28.31B |
| Biomarin Pharmaceutical Inc | 6.851B |
| Ionis Pharmaceuticals Inc | 3.081B |
| QuidelOrtho Corp | 6.801B |
| Moderna Inc | 15.80B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 664.74M |
| Shareholders Equity (Quarterly) | 237.12M |
| Debt to Equity Ratio | 1.907 |
| Current Ratio | 4.36 |
| Net Debt Paydown Yield | -2.04% |